SCHEMBL6985420

SCHEMBL6985420

COc1ccc(OC(C(C)O)N(Cc2ccccc2)Cc2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
ACHE P22303 1/20 0.46
LTA4H P09960 1/20 0.45
MAPK1 P28482 1/20 0.45
TSHR P16473 2/20 0.44
G6PC1 P35575 1/20 0.43
NPC1 O15118 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
TDP1 Q9NUW8 3/20 0.43
ALDH1A1 P00352 1/20 0.41
ALOX12 P18054 1/20 0.41
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RNF4 P78317 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6027885 0.91 SMN1; SMN2 (0.46) PPARGPPARATSHRNPC1MEN1
SCHEMBL7764648 0.86 KMT2A (0.47) PPARGPPARATSHRNPC1MEN1
SCHEMBL7609951 0.75 SMN1; SMN2 (0.36) TSHRNPC1MEN1KMT2APOLB
SCHEMBL7610980 0.74 MEN1 (0.44) MAPK1TSHRNPC1MEN1KMT2A
SCHEMBL8799638 0.73 RNF4 (0.47) ACHELTA4HMAPK1TSHRG6PC1
SCHEMBL7611484 0.73 ALDH1A1 (0.38) TSHRNPC1MEN1KMT2APOLB
SCHEMBL23363143 0.73 TRPA1 (0.40) TSHRMEN1KMT2APOLBTDP1
SCHEMBL4794172 0.72 ACHE (0.58) ACHEMAPK1NPC1MEN1KMT2A
SCHEMBL20871295 0.72 ALOX5 (0.51) ACHELTA4HTSHR
SCHEMBL10720380 0.72 PPARG (0.52) PPARGPPARAACHELTA4HTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1303510-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2003-04-23 EP disclosed
EP-1189901-A1 OXAZAHETEROCYCLES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-03-27 EP disclosed
WO-2002006248-A2 CYCLIC OXYGUANIDINE PYRAZINONES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-01-24 WO disclosed
WO-2000073302-A1 OXAZAHETEROCYCLES AS PROTEASE INHIBITORS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2000-12-07 WO disclosed